Brent Hatzis-Schoch

2020 - Black Diamond Therapeutics

In 2020, Brent Hatzis-Schoch earned a total compensation of $1.5M as Chief Operating Officer, General Counsel at Black Diamond Therapeutics.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$184,800
Option Awards$856,811
Salary$418,333
Other$17,100
Total$1,527,044

Hatzis-Schoch received $856.8K in option awards, accounting for 56% of the total pay in 2020.

Hatzis-Schoch also received $50K in bonus, $184.8K in non-equity incentive plan, $418.3K in salary and $17.1K in other compensation.

Rankings

In 2020, Brent Hatzis-Schoch's compensation ranked 6,758th out of 13,090 executives tracked by ExecPay. In other words, Hatzis-Schoch earned more than 48.4% of executives.

ClassificationRankingPercentile
All
6,758
out of 13,090
48th
Division
Manufacturing
2,817
out of 5,621
50th
Major group
Chemicals And Allied Products
1,138
out of 2,254
50th
Industry group
Drugs
981
out of 1,954
50th
Industry
Biological Products, Except Diagnostic Substances
235
out of 411
43rd
Source: SEC filing on April 28, 2022.

Hatzis-Schoch's colleagues

We found one more compensation record of an executive who worked with Brent Hatzis-Schoch at Black Diamond Therapeutics in 2020.

2020

David Epstein

Black Diamond Therapeutics

Chief Executive Officer

News

In-depth

You may also like